导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -17.70% | 961/1050 |
| 近一周 | -4.73% | 1049/1104 |
| 近一月 | -8.13% | 925/1102 |
| 近一季 | -11.05% | 718/1092 |
| 近半年 | -15.45% | 897/1070 |
| 近一年 | -20.58% | 909/1018 |
| 近两年 | 15.48% | 809/926 |
| 近三年 | 9.42% | 597/834 |
| 成立以来 | 21.48% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.91% 949/1070 |
-2.52% 742/1101 |
- - |
- - |
| 2025 | 25.06% 580/1065 |
11.80% 106/1014 |
1.40% 558/1038 |
17.77% 669/1050 |
-6.33% 758/1065 |
| 2024 | 19.44% 96/1011 |
2.08% 207/960 |
10.86% 11/983 |
6.36% 849/991 |
-0.78% 366/1011 |
| 2023 | -22.11% 728/952 |
-5.88% 815/880 |
-8.17% 697/895 |
-3.65% 234/915 |
-6.47% 635/952 |
| 2022 | -23.15% 443/867 |
-18.35% 446/773 |
5.34% 502/806 |
-18.22% 714/845 |
9.25% 91/867 |
| 2021 | -18.79% 529/740 |
-5.06% 341/580 |
10.21% 351/659 |
-15.36% 618/704 |
-8.31% 641/740 |
| 2020 | 45.92% 263/554 |
-6.41% 329/419 |
19.74% 289/466 |
11.22% 222/517 |
17.08% 167/554 |
| 2019 | 18.41% 334/410 |
- - |
- - |
- - |
- - |
| 2018 | -25.44% 154/349 |
- - |
- - |
- - |
- - |
| 2017 | 34.22% 25/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 华夏港股通精选股票发起式(LOF)A VS. 东吴新产业精选股票A(580008) |